scorecardresearch
Add as a preferred source on Google
Monday, January 5, 2026
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Trump eyes Pharma for next round of tariffs as 1st set of levies kicks in. India pushes for trade deal

India’s pharma industry relies heavily on US market, with $8.07 bn worth of exports in FY 2023-2024. Pharmaceuticals are India’s third largest goods exported to US in dollar terms.

Tariff cloud looming, US study links Indian generic drugs with 54% higher severe adverse events

Researchers associated with The Ohio State University found that number of severe adverse events linked to generic drugs made in India was 54% higher than for those made in the US.

SubscriberWrites: Pharma industry – Yearning for reforms

Despite the critical importance of the Pharma Industry, no attempts were made to resolve the issues & transform the industry.

Drug regulator tightens sampling norms to test quality of medicines & cosmetics reaching market

CDSCO last week notified streamlined guidelines on sampling, conceded that at present sampled drugs are mostly from big brands and urban areas. 

‘Can hamper entry of new drugs’ — groups raise alarm over IP proposals part of India-EFTA talks

India & EFTA (Iceland, Liechtenstein, Norway and Switzerland) are negotiating Trade and Economic Partnership Agreement (TEPA) that is likely to be finalized within next few weeks.

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.

Reporting faulty manufacture to annual audits: How govt wants drugmakers to improve quality

Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.

Slammed by industry, drugs bill set to get delayed as govt plans fresh panel for review

The Drugs, Medical Devices and Cosmetics Bill, 2023, is being planned as a substitute for the existing drug law, which was passed during the pre-Independence period.

Considering changes in pharmaceutical policy after cough syrup deaths, says PM Modi’s office

The document from Prime Minister Narendra Modi's office, which noted that ‘important things’ about the industry had been ‘overlooked’.

On Camera

BCCI has sabotaged India’s approach to Bangladesh

The BCCI decision has given new life to the lunatic fringe of the Hindu Right. It now has the confidence to force policy changes in accordance with its communal campaigns.

Trump threatens India with fresh tariffs on Russian oil, calls PM Modi a ‘good guy’

The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.